AIRE-1 Polyclonal Antibody

AIRE encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein (autoimmune regulator) plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED).

Introducing the AIRE-1 Polyclonal Antibody, a cutting-edge immunological tool designed to revolutionize research in the field of autoimmune disorders. This meticulously crafted antibody is derived from a diverse pool of B cells, ensuring a high degree of specificity and sensitivity in detecting the Autoimmune Regulator (AIRE) protein.

The AIRE-1 Polyclonal Antibody boasts exceptional affinity and selectivity, enabling accurate identification and quantification of AIRE protein expression levels in various biological samples. Its robust performance is further enhanced by its ability to recognize multiple epitopes on the AIRE protein, facilitating comprehensive analysis and characterization.

With its superior quality and reliability, the AIRE-1 Polyclonal Antibody guarantees reproducible results, making it an indispensable tool for researchers seeking to unravel the intricate mechanisms underlying autoimmune disorders. Its versatility extends to a wide range of applications, including immunohistochemistry, Western blotting, and flow cytometry, ensuring seamless integration into diverse experimental setups.

Furthermore, the AIRE-1 Polyclonal Antibody is meticulously manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to ensure consistent performance, providing researchers with the utmost confidence in their experimental outcomes.

In summary, the AIRE-1 Polyclonal Antibody represents a breakthrough in autoimmune disorder research, offering unparalleled sensitivity, specificity, and versatility. With its exceptional performance and stringent quality control, this antibody is poised to revolutionize the field, empowering researchers to unravel the complexities of autoimmune disorders with unprecedented precision and accuracy.